Introduction Chronic migraine is a neurological disorder characterized by headaches on 15 or more days per month, significantly affecting quality of life (1). The calcitonin gene-related peptide (CGRP) pathway is central to migraine pathophysiology, making monoclonal antibodies targeting the CGRP receptor a preventive treatment option (2). Erenumab
ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes
Catheter Ablation for Atrial Fibrillation with HF
691 Reached
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes
Young Girl Presented with Irritability and Abnormal Behavior
2253 Reached10 Comments4 Likes
Management of Infantile Myoclonic Seizures
1169 Reached3 Comments3 Likes